As the U.S. Food and Drug Administration weighs whether to require front-of-package food labels, a new study shows some food labels designed to nudge Americans toward healthier food choices can have ...

Citi initiated coverage on Cytokinetics (NASDAQ:CYTK) with a Buy rating and an $86.00 price target, representing significant upside from the current price of $46.17. The firm's analysts highlighted ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...